Background: Differential diagnosis of follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) is often difficult since presence or absence of capsular/vascular invasion can not be determined by preoperative fine needle aspiration cytology, and may not be judged unanimously on permanent sections even among experienced pathologists. Determination of molecular-genetic factors such as trefoil factor 3 (TFF3) mRNA in the follicular thyroid tumors may be useful aid to improve the accuracy of diagnosis, though it is considered to be unstable and relatively low concentrated genetic substance. Purpose of our study is to investigate expression level of TFF3 mRNA of thyroid follicular tumors using formalin-fixed, paraffin-embedded (FFPE) tissue. Methods: Study population included FFPE sections from 19 FTC cases, 20 FTA cases, 11 adenomatous goiter (G) cases and 12 samples of normal thyroid tissue (N) adjacent to thyroid tumors. RNeasy FFPE kit was used for extraction of total RNA. Purification and concentration values were determined by spectrophotometer. Extracted RNA was used for cDNA synthesis in reverse transcription. Synthesized cDNA subsequently proceeded for relative quantification of TFF3 mRNA by RT-qPCR using TFF3 primers. Glyceroldehyde-3-phosphate dehydrogenase (GAPDH) and hypoxanthin phosphorobosyltransferase1 (HPRT1) were used as control genes. The mean and standard deviation of TFF3 mRNA expression level were analyzed by software Multiplate RQ. Results: Extraction by the FFPE kit yielded high concentration of RNA in all cases. Purification values were 1.8 in average. Concentration values were significantly higher in FTC and FTA relative to G and N tissues, possibly due to high density of thyrocytes in the samples. Relative quantification of TFF3 mRNA expression level showed broad ranges both in FTC and FTA, while the analyses in G and N tissues indicated narrow ranges. Conclusion: FFPE tissues from thyroid follicular tumors can be used for measurement of unstable and low concentrated genetic substances such as TFF3 mRNA. Its diagnostic value yet remains to be determined.
Introduction
The histological classification of thyroid epithelial tumors is the current standard to distinguish benign from malignant thyroid tumors and to assign specific tumors into histological subtypes. The World Health Organization (WHO) classification has recently been revised and distinguishes thyroid tumor types [1] . For many of these tumor types, the histological criteria are subjective and thus difficult to implement. Furthermore, reliable biologic prognostic factors are still lacking [2] .
Since the introduction of fine needle aspiration biopsy (FNAB) in the early 1970s, diagnosis of the majority of thyroid malignancies, especially that of papillary carcinoma, can be made without much difficulty [3] . However, preoperative diagnosis of follicular carcinoma still remains difficult since capsular or vascular invasion is not possible to determine cytologically. When the tumors can not be diagnosed by cytological examinations, identification of a definite molecular marker is crucial for establishment of a preoperative test to diagnose follicular carcinoma.
Recently proposed marker genes in thyroid tumors are adrenomedullin-3 (ADM3) [4] , cyclin D2 (CCND2), prostate differentiation factor (PLAB), proprotein convertase subtilisin/kexin type 2 (PCSK2) [5] , lectin, galactosidebinding, soluble, 3 (LGALS3), trefoil factor 3 (TFF3) [6] [7] [8] , beta-1,4-galactosyltransferase (B4GALT), HGD1 [9] , thyroglobulin (TG), and v-etserythroblastosis virus E26 oncogene homolog 1 (ETS1) [10] .
While other markers failed to show reproducible results in follow-up studies, researches at other institutes revealed the utility of TFF3 mRNA for the diagnosis of thyroid tumors including follicular carcinoma [11] [12] [13] .
Upregulation of TFF3 is observed in normal thyroid tissues, adenomatous goiters, 80% of follicular adenomas, and 20% of minimally invasive follicular carcinomas, while downregulation is observed in anaplastic carcinomas, papillary carcinomas, widely invasive follicular carcinomas, 80% of minimally invasive follicular carcinomas, and 20% of follicular adenomas [7, 11, 13] . Thus, TFF3 mRNA is a universal indicator for thyroid tumors derived from thyroid follicular cells.
Thus, TFF3 mRNA is now regarded to be the best marker to distinguish thyroid malignancies including follicular carcinoma. However, there are still several problems to be solved. First of all, TFF3-based diagnosis is not perfectly match with the pathological diagnosis. This discrepancy is the most evident in the diagnosis of minimally invasive follicular carcinoma. This may indicate that the pathological diagnosis of minimally invasive carcinoma does not always reflect the biological features of thyroid tumor cells. So, the reasons for discrepant results obtained between TFF3-based and pathological diagnosis remain unclear.
When a pathologist gives the conclusion that resected thyroid tumor is benign, but recommends follow up, since presence of follicular thyroid carcinoma can not be excluded confidentially, such a follicular adenomas were classified as "suspicious". Our idea is to show that, the useful results may be obtained even using formalin-fixed, paraffin-embedded (FFPE) blocks. Our study is first report that have extracted and examined TTF-3 RNA from the paraffin blocks of follicular thyroid tumors. That is why we choose FFPE tissue for analysis. We did not study cytology specimen. Specimens were microdissected from resected thyroid tissues that had been sent from endocrine surgery department to pathology department. In the available literature we found only few studies concerning RNA studies [14] [15] [16] and no study was found on TFF3 expression level in FFPE thyroid tissue.
Thus, the purpose of our study is to investigate recently proposed tumor marker TFF3 mRNA expression level for the differential diagnosis of follicular thyroid adenoma and follicular thyroid carcinoma using FFPE tissue.
Materials and Methods

Thyroid Samples
Diagnosis of follicular thyroid tumors were established according to signs of clinical manifestation, ultrasonography, FNAC, intraoperative inspection, final pathology and classified according to function and histology as previously described [1, 2] . Expression level of trefoil factor 3 (TFF3) mRNA was studied in formalin-fixed, paraffin-embedded (FFPE) blocks of follicular thyroid tumors. The study population included FFPE sections from 19 follicular thyroid carcinoma (FTC) cases, 20 follicular thyroid adenoma (FTA) cases, 11 adenomatous goiter (G) cases and 12 samples of normal thyroid tissue (N) adjacent to thyroid tumors (1 -5 years of archival time). G and N samples were used as a control group. There are five cases of FTA were classified as a suspicious follicular thyroid adenoma due to the pathological findings and required follow up.
FFPE blocks of thyroid samples were obtained from the Department of Endocrine Surgery, Tokyo Women's Medical University, Japan.
RNA Extraction, cDNA Synthesis and RT-qPCR
Before proceeding to RNA extraction, FFPE blocks of thyroid samples were once more confirmed for their correspondence to assumed thyroid pathology by conventional HE staining using 4 μm section. Then, 10 μm of FFPE block 4 -5 sections were collected in to 2 ml tube at sterile conditions. The microtome, all equipment and instruments were cleaned up by 70% ethanol to avoid RNA degradation and decreasing of RNA yield. Collected tissue samples were deparaffinized with xylene, homogenized and transferred for RNA extraction. RNA clean up was performed using the RNeasy FFPE Kit (Qiagen Sciences, MD, USA) according to manufactures protocol.
Spectrophotometry of extracted total RNA was carried out to calculate purification and concentration values. Purification value is calculated as ratio A260/A280. Concentration value is calculated according to dilution index as follow: CV = A260  50  40 (ng/μl) (U-2000A spectrophotometer, HITACHI, Tokyo, Japan). In case of low RNA yield the extraction procedure was repeated until enough amount of total RNA is collected.
Total RNA (1 μg) was reverse transcribed in a 20 μl reaction. The reaction mixture consisted of 4 μl 5 × PrimeScript Buffer, 1 μl Enzyme Mix, 1 μl oligod NTP, 1 μl Random 6 merand 13 μl dH 2 O containing 1 μg RNA. Shortly centrifuged in 10,000 rpm for 10 sec. Reverse transcription was performed at 37˚C for 15 min and at 85˚C for 1 min. Tube containing synthesized сDNA is delivered on ice and stored at −20˚C.
Real-time quantitative polymerase chain reaction using the Thermal Cycler Dice Real Time System Multiplate RQ (Takara TP800, Tokyo, Japan) and Takara qPCR set, including SYBR Premix ExTaq II, was performed according to the manufacturer's protocol. Four microliter of the first strand cDNA was used in the following assay. The sequences of TFF3 Primers were 5'-AATGCACCTT-CTGAGGCACCT-3' (coding sense corresponding to base 452 -472), 5'-CGTTAAGACATCAGGCTCCAGAT-3' (anti codinf sense corresponding to base 623 -601) (8) . Glyceroldehyde-3-phosphate dehydrogenase (GAPDH) (HA067812, Takara, Tokyo, Japan) and hypoxanthin phosphorobosyltransferase1 (HPRT1) (HA 067805, Takara, Tokyo, Japan) were used as control genes. All primers were purchased from Takara (Tokyo, Japan). 3 steps PCR were used. The conditions for PCR were as follows: 95˚C for 2 minutes and 50 cycles of 95˚C for 15 seconds and 60˚C for 1 minute. Negative control tubes did not contain primers, Calibration tubes contain FTC culture cells cDNA (target sample).
Gel electrophoresis. After amplification of DNA via PCR DNA Gel electrophoresis have been performed to check out quality of amplification of PCR products.
Statistical Analysis
The Mann-Whitney U test was used to compare TFF3-mRNA expression level in follicular thyroid adenoma, follicular thyroid carcinoma, adenomatous goiter and normal thyroid tissues using software Multiplate RQ (Takara).
Results
Study groups included patients, who received surgical treatment according to different surgical diseases of thyroid gland. After conventional histology established final diagnosis formalin-fixed, paraffin-embedded (FFPE) blocks of thyroid tumors were collected for study. The tumor area was checked by HE staining, and only tumor parts were collected from the next continuation sections. Normal tissue, adenomatous goiter, follicular adenoma, minimal invasive follicular carcinoma, wide invasive follicular carcinoma parts were also collected after checking by HE staining (Figure 1) .
Patients were assigned into 4 groups: 19 follicular thyroid carcinoma (FTC) cases, 20 follicular thyroid adenoma (FTA) cases, 11 adenomatous goiter (G) cases and 12 samples of normal thyroid tissue (N) adjacent to thyroid tumors were included in the study. There are five cases of FTA were classified as a suspicious follicular thyroid adenoma due to the pathological findings and required follow up. Using the RNeasy FFPE Kit (Qiagen) yielded high concentration of RNA in all cases. Purification and concentration values of extracted total RNA are presented in Table 1 . 
Figure 1. Morphological examination of thyroid tissues. (A) Normal tissue, (B) Adenomatous goiter, (C) Follicular adenoma, (D) Minimal invasive follicular carcinoma, (E) Wide invasive follicular carcinoma. Arrows indicate invasion area. Arrow heads indicate wide invasion (×4). Bottom right squares show cell atypia in high magnification (×40).
As it is seen from Table 1 , all FFPE thyroid samples contain enough amount of RNA for reverse transcription. Concentration values were significantly higher in FTC and FTA relative to G and N tissues, possibly due to high density of thyrocytes in the samples. This difference is seen in spectrophotometer curve of Figure 2 .
All extracted RNA from samples were immediately reverse transcribed for cDNA synthesis.
In order to check the conditions of the real time PCR, gel electrophoresis was performed for the sample of each group. The amplified band was detected an expected position in all samples. Real time PCR was performed on this condition (Figure 3) . Synthesized cDNA is used in real-time PCR for relative quantification of TFF3 mRNA expression level in all samples. When the appropriate cutoff point was set and questionable cases related to contamination and not amplified samples during the RT-qPCR were excluded we get results as in Figure 4 .
Relative quantification of TFF3 mRNA expression level showed broad ranges both in FTC and FTA (2554.8 ± 1321.9 and 5244.3 ± 3796.2 respectively, P > 0.05), while the analyses in G and N tissues indicated narrow ranges (2492 ± 601.7 and 4939.7 ± 440.9 respectively, P < 0.05). Our findings showed broad range of TFF3 mRNA expression level both in FTC and FTA, while the analyses in G and N tissues indicated narrow ranges using descriptive statistics (Figure 4) .
In our study TFF3 does not perfectly match with the pathological diagnosis of follicular thyroid tumors, though we can see tendency of upregulation and downregulation of TFF3 mRNA expression level in different thyroid tumors while grading the results. Downregulation of TFF3 is observed in 67% FTC and in 100% suspicious follicular thyroid adenoma that require follow up as pathologist indicated, while upregulation of TFF3 is observed in 53% FTA. TFF3 levels are evenly distributed in normal thyroid tissues and adenomatous goiters.
Discussion
Differential expression of TFF3 mRNA between follicular adenomas and carcinomas was first reported in detail by Takano T. et al., using serial analysis of gene expression (SAGE) in 2004 [7] . Authors estimated the efficiency of differential diagnosis between follicular adenoma and carcinoma by measuring the expression levels of TFF3 mRNA. In the 54 follicular adenomas and 29 follicular carcinomas analyzed, the relative expression of TFF3 mRNA was markedly decreased in 7 follicular carcinomas of the widely invasive type and with evident distant metastases. When the appropriate cutoff point was set and pathologically questionable cases were excluded, the sensitivity, specificity and accuracy were 80.0%, 91.5%, and 87.5%, respectively [6] . Taniguchi et al. used a unique system for analysis of gene expression called Adapter-Tagged competitive PCR, to screen over 2000 genes expressed in thyroid follicular tumors and concluded that TFF3 mRNA is one of the most promising markers for diagnosing follicular carcinoma [12] . Foukakis et al. reevaluated 26 previously reported candidate genes and found that the combination of TFF3 and hTERT mRNA could most efficiently distinguish follicular carcinomas from adenomas [11] . Another re-evaluation had performed by Krause et al., who examined 10 candidate genes and found that downergulation of TFF3 in malignant tumors was the best indicator for thyroid malignancies including follicular carcinoma and any combination assays that include TFF3 could efficiently distinguish follicular carcinomas from adenomas [13] .
Molecular-based diagnosis of anaplastic and papillary carcinomas can be established easily with genes overexpressed restrictedly in these tumors in clear contrast to follicular carcinoma [17] [18] [19] . The reason why TFF3 is downregulated in follicular carcinomas is not clear at present. It is also unclear how far environmental factors, such as iodine supply, may influence the candidate gene expression. The further investigation to clarify this phenomenon may give a clue to understand the very fundamental mechanism of thyroid carcinogenesis.
Differential diagnosis FTC from FTA is often difficult since presence or absence of capsular/vascular invasion can not be determined by preoperative fine needle aspiration cytology, and may not be judged unanimously on permanent sections even among experienced pathologists. Determination of molecular-genetic factors such as TFF3 mRNA in the follicular thyroid tumors may be useful aid to improve the accuracy of diagnosis. In fact, our results showed that expression level of TFF3 mRNA was associated with histopathological diagnoses, although the relationship should be interpreted with caution. Though we found that 100% suspicious follicular thyroid adenomas and 67% of FTC correlate with downregulation of TTF3. We speculate that some other risk factors are also should be taken into account while determining subgroup of patients with TFF3 downregulation and upregulation. Perhaps TFF3 must be analyzed in correlation with other risk factors such as TNM, age, gender, Tg and others to identified subgroups with significant data of TFF3 upregulation and downregulation appropriate to these correlations.
Another important point is that we tried to confirm the utility of this approach by using archival thyroid tissues-FFPE blocks. Human surgical tissue samples are routinely fixed with formalin and then embedded in paraffin for long-term preservation. The extensive histopathology archive of FFPE tissue samples represents an extremely valuable resource for retrospective studies of gene expression patterns in diseased tissues. Limitations on using these samples for mRNA expression studies have been imposed by the significant modification and degradation of RNA during tissue fixation, resulting in poor yield of RNA. In our study we revealed that FFPE blocks of thyroid diseased tissue with the archival time 1 -5 years can be used for RNA extraction with the high yield of RNA. Purification values were in average 1.8. Concentration values were significantly higher in FTC and FTA relative to G and N tissues, possibly due to high density of thyrocytes in the samples.
Determination of molecular-genetic factors such as TFF3 mRNA in correlation with other risk factors in the follicular thyroid tumors may be useful aid to improve the accuracy of diagnosis, though it is considered to be unstable and relatively low concentrated genetic substance. Results of our study indicate the applicability of mRNA expression patterns as potential markers of human cancer, and our results suggest that FFPE tissues are suitable resources for mRNA expression analyses. FFPE tissues from thyroid follicular tumors can be used for measurement of unstable and low concentrated genetic substances such as TFF3 mRNA. Meanwhile, its diagnostic value yet remains to be determined.
